Indication
Acute Gastritis
2 clinical trials
3 products
Product
DA-5219Product
StillenClinical trial
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic GastritisStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. in Korean Patients With Acute or Chronic Gastritis in Accordance With Korean Regulation, 'Standard for Re-examination of New Drugs'Status: Recruiting, Estimated PCD: 2024-12-15
Product
Mucosta SR